A PYMNTS Company

Bausch + Lomb gets early termination of HSR waiting period for ISTA acquisition

 |  April 24, 2012

Bausch + Lomb has received early termination of the Hart-Scott-Rodino waiting period for its pending acquisition of ISTA Pharmaceuticals. California-based ISTA is the third-largest branded prescription eye care business in the United States. Bausch + Lomb is headquarted in New York; its core businesses center around contact lenses and other ophthalmic products.

Full content: MarketWatch


Related contentThe AZ Judgment: A Green Light for Further Action on Pharma and IP (Sean-Paul Brankin, Crowell & Moring)


Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.